Literature DB >> 7753126

Differential electrophysiological features of neuropathies associated with 17p11.2 deletion and duplication.

A Uncini1, G Di Guglielmo, A Di Muzio, D Gambi, M Sabatelli, T Mignogna, P Tonali, R Marzella, P Finelli, N Archidiacono.   

Abstract

UNLABELLED: Hereditary neuropathy with liability to pressure palsies (HNPP) and hereditary motor-sensory neuropathy type IA (HMSN IA) are quite distinct clinical entities recently associated to deletion and duplication, respectively, of the 17p11.2 segment including the gene for peripheral myelin protein 22 (PMP-22). We studied the electrophysiological features of 48 HNPP and 62 HMSN IA motor nerves. Conduction velocities (CV) and compound muscle action potential amplitudes were significantly reduced and distal latencies prolonged in HMSN IA compared to HNPP. CV was uniformly slowed in HMSN IA nerves whereas in HNPP it was focally slowed in 80% of ulnar and 12% of peroneal nerves at usual compression sites. Conduction block was present in 6% of HNPP nerves but in none of HMSN IA. IN
CONCLUSION: (1) HMSN IA with 17p11.2 duplication presents marked, diffuse, and uniform slowing; (2) HNPP with 17p11.2 deletion presents focal electrophysiological abnormalities possibly correlated with the presence of tomaculae; and (3) under- and overexpression of PMP-22 in concurrence with environmental factors might be responsible for the distinctive features of HNPP and HMSN IA.

Entities:  

Mesh:

Year:  1995        PMID: 7753126     DOI: 10.1002/mus.880180610

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation.

Authors:  E Andreadou; C Yapijakis; G P Paraskevas; P Stavropoulos; C Karadimas; V P Zis; P Davaki; N Karandreas; M Rentzos; C Tsakanikas; D Vassilopoulos; C Papageorgiou
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 2.  Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies.

Authors:  Kinga Szigeti; Eva Nelis; James R Lupski
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  Hereditary neuropathy with liability to pressure palsies.

Authors:  Shahram Attarian; Farzad Fatehi; Yusuf A Rajabally; Davide Pareyson
Journal:  J Neurol       Date:  2019-04-15       Impact factor: 4.849

Review 4.  Inherited neuropathies and deafness caused by a PMP22 point mutation: a case report and a review of the literature.

Authors:  Marco Luigetti; Marcella Zollino; Guido Conti; Angela Romano; Mario Sabatelli
Journal:  Neurol Sci       Date:  2012-12-24       Impact factor: 3.307

Review 5.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Atypical hereditary neuropathy with liability to pressure palsies (HNPP): the value of direct DNA diagnosis.

Authors:  M Sessa; R Nemni; A Quattrini; U Del Carro; L Wrabetz; N Canal
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

7.  Electrophysiological comparison between males and females in HNPP.

Authors:  Fiore Manganelli; Chiara Pisciotta; Raffaele Dubbioso; Valerio Maruotti; Rosa Iodice; Francesca Notturno; Lucia Ruggiero; Carmine Vitale; Maria Nolano; Antonino Uncini; Lucio Santoro
Journal:  Neurol Sci       Date:  2012-12-04       Impact factor: 3.307

Review 8.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

Review 9.  PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.

Authors:  Barbara W van Paassen; Anneke J van der Kooi; Karin Y van Spaendonck-Zwarts; Camiel Verhamme; Frank Baas; Marianne de Visser
Journal:  Orphanet J Rare Dis       Date:  2014-03-19       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.